BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

401 related articles for article (PubMed ID: 10898795)

  • 21. NAC1, a POZ/BTB protein that functions as a corepressor.
    Korutla L; Wang P; Jackson TG; Mackler SA
    Neurochem Int; 2009; 54(3-4):245-52. PubMed ID: 19121354
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MBD3L2 interacts with MBD3 and components of the NuRD complex and can oppose MBD2-MeCP1-mediated methylation silencing.
    Jin SG; Jiang CL; Rauch T; Li H; Pfeifer GP
    J Biol Chem; 2005 Apr; 280(13):12700-9. PubMed ID: 15701600
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A new functional domain of Bcl6 family that recruits histone deacetylases.
    Zhang H; Okada S; Hatano M; Okabe S; Tokuhisa T
    Biochim Biophys Acta; 2001 Sep; 1540(3):188-200. PubMed ID: 11583814
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ETO, a target of t(8;21) in acute leukemia, makes distinct contacts with multiple histone deacetylases and binds mSin3A through its oligomerization domain.
    Amann JM; Nip J; Strom DK; Lutterbach B; Harada H; Lenny N; Downing JR; Meyers S; Hiebert SW
    Mol Cell Biol; 2001 Oct; 21(19):6470-83. PubMed ID: 11533236
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interferon regulatory factor 8 (IRF8) interacts with the B cell lymphoma 6 (BCL6) corepressor BCOR.
    Yoon J; Feng X; Kim YS; Shin DM; Hatzi K; Wang H; Morse HC
    J Biol Chem; 2014 Dec; 289(49):34250-7. PubMed ID: 25331958
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Colocalization and heteromerization between the two human oncogene POZ/zinc finger proteins, LAZ3 (BCL6) and PLZF.
    Dhordain P; Albagli O; Honore N; Guidez F; Lantoine D; Schmid M; The HD; Zelent A; Koken MH
    Oncogene; 2000 Dec; 19(54):6240-50. PubMed ID: 11175338
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multiple regions of ETO cooperate in transcriptional repression.
    Hildebrand D; Tiefenbach J; Heinzel T; Grez M; Maurer AB
    J Biol Chem; 2001 Mar; 276(13):9889-95. PubMed ID: 11150306
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The mixed lineage leukemia fusion partner AF9 binds specific isoforms of the BCL-6 corepressor.
    Srinivasan RS; de Erkenez AC; Hemenway CS
    Oncogene; 2003 May; 22(22):3395-406. PubMed ID: 12776190
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ETO protein of t(8;21) AML is a corepressor for Bcl-6 B-cell lymphoma oncoprotein.
    Chevallier N; Corcoran CM; Lennon C; Hyjek E; Chadburn A; Bardwell VJ; Licht JD; Melnick A
    Blood; 2004 Feb; 103(4):1454-63. PubMed ID: 14551142
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Point mutations in BCL6 DNA-binding domain reveal distinct roles for the six zinc fingers.
    Mascle X; Albagli O; Lemercier C
    Biochem Biophys Res Commun; 2003 Jan; 300(2):391-6. PubMed ID: 12504096
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HoxA10 represses gene transcription in undifferentiated myeloid cells by interaction with histone deacetylase 2.
    Lu Y; Goldenberg I; Bei L; Andrejic J; Eklund EA
    J Biol Chem; 2003 Nov; 278(48):47792-802. PubMed ID: 14512427
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Specific peptide interference reveals BCL6 transcriptional and oncogenic mechanisms in B-cell lymphoma cells.
    Polo JM; Dell'Oso T; Ranuncolo SM; Cerchietti L; Beck D; Da Silva GF; Prive GG; Licht JD; Melnick A
    Nat Med; 2004 Dec; 10(12):1329-35. PubMed ID: 15531890
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The proto-oncoprotein FBI-1 interacts with MBD3 to recruit the Mi-2/NuRD-HDAC complex and BCoR and to silence p21WAF/CDKN1A by DNA methylation.
    Choi WI; Jeon BN; Yoon JH; Koh DI; Kim MH; Yu MY; Lee KM; Kim Y; Kim K; Hur SS; Lee CE; Kim KS; Hur MW
    Nucleic Acids Res; 2013 Jul; 41(13):6403-20. PubMed ID: 23658227
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Btf, a novel death-promoting transcriptional repressor that interacts with Bcl-2-related proteins.
    Kasof GM; Goyal L; White E
    Mol Cell Biol; 1999 Jun; 19(6):4390-404. PubMed ID: 10330179
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structure of a BCOR corepressor peptide in complex with the BCL6 BTB domain dimer.
    Ghetu AF; Corcoran CM; Cerchietti L; Bardwell VJ; Melnick A; Privé GG
    Mol Cell; 2008 Feb; 29(3):384-91. PubMed ID: 18280243
    [TBL] [Abstract][Full Text] [Related]  

  • 36. JMJD2A is a novel N-CoR-interacting protein and is involved in repression of the human transcription factor achaete scute-like homologue 2 (ASCL2/Hash2).
    Zhang D; Yoon HG; Wong J
    Mol Cell Biol; 2005 Aug; 25(15):6404-14. PubMed ID: 16024779
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of COOH-terminal-binding protein (CtBP) and MEF2-interacting transcription repressor (MITR) contributes to transcriptional repression of the MEF2 transcription factor.
    Zhang CL; McKinsey TA; Lu JR; Olson EN
    J Biol Chem; 2001 Jan; 276(1):35-9. PubMed ID: 11022042
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Involvement of a novel zinc finger protein, MIZF, in transcriptional repression by interacting with a methyl-CpG-binding protein, MBD2.
    Sekimata M; Takahashi A; Murakami-Sekimata A; Homma Y
    J Biol Chem; 2001 Nov; 276(46):42632-8. PubMed ID: 11553631
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The human programmed cell death-2 (PDCD2) gene is a target of BCL6 repression: implications for a role of BCL6 in the down-regulation of apoptosis.
    Baron BW; Anastasi J; Thirman MJ; Furukawa Y; Fears S; Kim DC; Simone F; Birkenbach M; Montag A; Sadhu A; Zeleznik-Le N; McKeithan TW
    Proc Natl Acad Sci U S A; 2002 Mar; 99(5):2860-5. PubMed ID: 11854457
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MLL repression domain interacts with histone deacetylases, the polycomb group proteins HPC2 and BMI-1, and the corepressor C-terminal-binding protein.
    Xia ZB; Anderson M; Diaz MO; Zeleznik-Le NJ
    Proc Natl Acad Sci U S A; 2003 Jul; 100(14):8342-7. PubMed ID: 12829790
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.